<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://depot.umc.edu.dz/handle/123456789/14452">
<title>Oral communication</title>
<link>http://depot.umc.edu.dz/handle/123456789/14452</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://depot.umc.edu.dz/handle/123456789/14701"/>
</rdf:Seq>
</items>
<dc:date>2026-06-02T07:37:17Z</dc:date>
</channel>
<item rdf:about="http://depot.umc.edu.dz/handle/123456789/14701">
<title>BO-01 : Docking of nitrovinylfuran derivatives against SARS CoV-2 main  protease for the treatment of covid-19</title>
<link>http://depot.umc.edu.dz/handle/123456789/14701</link>
<description>BO-01 : Docking of nitrovinylfuran derivatives against SARS CoV-2 main  protease for the treatment of covid-19
BOULHISSA, Ilham; CHIKHI, Abdelouahab; BENSEGUEN, Abderrahmane
Covid-19 has become one of the most known pandemics in the world wide, &#13;
it was appeared in late of December 2019 from Wuhan city of China. The research to fight covid19 is &#13;
ongoing without finding any efficient treatment still now.   &#13;
Objectives: This work aims to identify new anticovid19 agents by a virtual screening of the &#13;
nitrovinylfuran derivatives as new inhibitors of the SARS CoV-2 main protease (Mpro), implicated in &#13;
the replication of the virus.   &#13;
Methods: A set of nitrovinylfuran derivatives were docked in the structure of Mpro (downloaded &#13;
from PDB), and then filtered according to their good ADME-T profile using two web servers.   &#13;
Results and discussion: Two nitrovinylfuran derivatives  PubChem-57392921 and PubChem&#13;
88580143 showed good interaction energy scores with the binding site of SARS CoV-2 Mpro. In &#13;
addition, they were found having good pharmacokenitic properties and a low toxicity.  &#13;
Conclusion: Our research proposed two nitrovinylfuran derivatives as potential inhibitors of &#13;
SARS CoV2 Mpro, other practical investigations on the nitrovinylfuran derivatives could enrich the &#13;
treatment of covid19 by new antiviral agents
</description>
<dc:date>2023-10-05T00:00:00Z</dc:date>
</item>
</rdf:RDF>
